Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fulgent Genetics Inc 4399 SANTA ANITA AVENUE EL MONTE CA 91731 USA

www.fulgentgenetics.com Employees: 1,313 P: 626-350-0537 F: 626-454-1667

Sector:

Medical

Description:

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.

Key Statistics

Overview:

Market Capitalization, $K 838,952
Enterprise Value, $K 783,812
Shares Outstanding, K 30,912
Annual Sales, $ 283,470 K
Annual Net Income, $ -42,710 K
Last Quarter Sales, $ 84,070 K
Last Quarter Net Income, $ -6,610 K
EBIT, $ -63,000 K
EBITDA, $ -43,620 K
60-Month Beta 0.65
% of Insider Shareholders 31.76%
% of Institutional Shareholders 48.06%
Float, K 21,094
% Float 68.24%
Short Volume Ratio 0.43

Growth:

1-Year Return 34.09%
3-Year Return -13.04%
5-Year Return -38.82%
5-Year Revenue Growth 771.41%
5-Year Earnings Growth -3,450.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.14 on 11/07/25
Next Earnings Date 02/27/26
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr 36.00%
EPS Growth vs. Prev Year -220.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

FLGT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2.55%
Return-on-Assets % -2.36%
Profit Margin % -15.07%
Debt/Equity 0.00
Price/Sales 2.95
Price/Cash Flow N/A
Price/Book 0.74
Book Value/Share 36.61
Interest Coverage -306.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar